生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Necrosulfonamide functions as an inhibitor of necroptosis by selectively inhibiting the mixed lineage kinase domain-like protein (MLKL). It obstructs the interaction between the MLKL-RIP1-RIP3 necrosome complex and its subsequent effectors. During necrosis initiation, MLKL is an essential target of RIP3. Necrosulfonamide acts downstream of RIP3 activation to specifically impede necrosis. It hinders necrosis driven by MLKL by inhibiting the functionality of its N-terminal CC domain[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.17mL 0.43mL 0.22mL |
10.83mL 2.17mL 1.08mL |
21.67mL 4.33mL 2.17mL |
参考文献 |
---|